Y. Hiraga

Increased monoamine oxidase activity and vitamin B-12 deficiency in dementia disorders

L. Oreland, C. Gottfries, B. Regland, 1990 .

The cholinergic neurotoxin ethylcholine mustard aziridinium (AF64A) induces an increase in MAO-B activity in the rat brain

L. Oreland, S. S. Jossan, Y. Hiraga, 1989, Brain Research.

A comparison of intraperitoneal injection and oral gavage in the micronucleus test with mitomycin C in mice.

S. Sato, N. Inui, Y. Ikeda, 1989, Mutation research.

Pharmacokinetics and Safety of Z‐321, a Novel Specific Orally Active Prolyl Endopeptidase Inhibitor, in Healthy Male Volunteers

M. Nakashima, Y. Ikeda, K. Umemura, 1999, Journal of clinical pharmacology.

[Relationship between cholinergic symptoms caused by distigmine and the activities of serum AChE and BChE].

K. Nakayama, S. Ushijima, Y. Tanaka, 1997, Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology.

Effects of cholinergic and monoaminergic antagonists and tranquilizers upon spatial memory in rats

T. Iwasaki, Y. Hiraga, 1984, Pharmacology Biochemistry and Behavior.

Hippocampal Serotonin 5‐HT1A Receptor Enhances Acetylcholine Release in Conscious Rats

J. Izumi, Y. Hiraga, N. Miura, 1994, Journal of neurochemistry.

Improving effects of FG-7080, a serotonin reuptake inhibitor, on scopolamine-induced performance deficits of memory tasks in rats.

T. Iwasaki, N. Nakata, Y. Hiraga, 1993, Japanese journal of pharmacology.